Christopher Francis Rowley, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Drug Resistance, Viral | 8 | 2022 | 859 | 1.250 |
Why?
|
Substance Abuse, Intravenous | 2 | 2020 | 529 | 0.870 |
Why?
|
Splenic Diseases | 1 | 2017 | 90 | 0.540 |
Why?
|
Babesiosis | 1 | 2017 | 92 | 0.520 |
Why?
|
Crisis Intervention | 1 | 2015 | 110 | 0.480 |
Why?
|
Nevirapine | 3 | 2010 | 273 | 0.470 |
Why?
|
HIV Infections | 12 | 2022 | 17159 | 0.460 |
Why?
|
HIV-1 | 9 | 2022 | 6850 | 0.460 |
Why?
|
Opioid-Related Disorders | 2 | 2020 | 2135 | 0.450 |
Why?
|
Anti-HIV Agents | 9 | 2022 | 4492 | 0.420 |
Why?
|
HIV | 3 | 2016 | 1579 | 0.400 |
Why?
|
Endocarditis | 1 | 2015 | 351 | 0.380 |
Why?
|
Physician's Role | 1 | 2017 | 920 | 0.360 |
Why?
|
DNA Primers | 2 | 2021 | 2819 | 0.360 |
Why?
|
Botswana | 6 | 2022 | 1042 | 0.340 |
Why?
|
Reverse Transcriptase Inhibitors | 2 | 2010 | 618 | 0.330 |
Why?
|
Polymerase Chain Reaction | 3 | 2021 | 6067 | 0.300 |
Why?
|
Drug Monitoring | 1 | 2013 | 966 | 0.290 |
Why?
|
Antiretroviral Therapy, Highly Active | 3 | 2012 | 1894 | 0.240 |
Why?
|
Hemorrhage | 1 | 2017 | 3604 | 0.240 |
Why?
|
Virology | 1 | 2021 | 74 | 0.180 |
Why?
|
Bacteriophages | 1 | 2024 | 373 | 0.180 |
Why?
|
Osteomyelitis | 1 | 2024 | 407 | 0.170 |
Why?
|
Heterocyclic Compounds, 3-Ring | 2 | 2019 | 275 | 0.160 |
Why?
|
Substance-Related Disorders | 1 | 2015 | 4370 | 0.160 |
Why?
|
HIV Integrase | 1 | 2019 | 121 | 0.160 |
Why?
|
Drug Resistance, Multiple, Viral | 1 | 2018 | 53 | 0.160 |
Why?
|
Prosthesis-Related Infections | 1 | 2024 | 486 | 0.160 |
Why?
|
Drug Users | 1 | 2020 | 132 | 0.150 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2010 | 2127 | 0.150 |
Why?
|
HIV Integrase Inhibitors | 1 | 2019 | 165 | 0.150 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 7400 | 0.140 |
Why?
|
Polymorphism, Genetic | 1 | 2008 | 4286 | 0.140 |
Why?
|
Infectious Mononucleosis | 1 | 2017 | 133 | 0.140 |
Why?
|
Mutation, Missense | 3 | 2018 | 2563 | 0.130 |
Why?
|
Narcotic Antagonists | 2 | 2018 | 582 | 0.130 |
Why?
|
CD4 Lymphocyte Count | 3 | 2013 | 2569 | 0.130 |
Why?
|
Point Mutation | 1 | 2021 | 1594 | 0.130 |
Why?
|
DNA, Viral | 2 | 2021 | 2195 | 0.130 |
Why?
|
Stereotyping | 1 | 2017 | 239 | 0.130 |
Why?
|
Naloxone | 1 | 2018 | 369 | 0.130 |
Why?
|
Viral Load | 4 | 2022 | 3323 | 0.120 |
Why?
|
Hepatitis C | 1 | 2005 | 1578 | 0.120 |
Why?
|
Influenza Vaccines | 1 | 2022 | 770 | 0.120 |
Why?
|
Vaccines | 1 | 2021 | 833 | 0.110 |
Why?
|
Injections | 1 | 2015 | 830 | 0.100 |
Why?
|
Dideoxynucleosides | 1 | 2012 | 132 | 0.100 |
Why?
|
Nursing Homes | 3 | 2022 | 1076 | 0.090 |
Why?
|
Buprenorphine | 1 | 2017 | 653 | 0.080 |
Why?
|
RNA, Viral | 3 | 2019 | 2837 | 0.080 |
Why?
|
Humans | 26 | 2024 | 760261 | 0.080 |
Why?
|
HLA-B Antigens | 1 | 2008 | 331 | 0.070 |
Why?
|
Parvoviridae Infections | 1 | 2007 | 36 | 0.070 |
Why?
|
Parvovirus B19, Human | 1 | 2007 | 40 | 0.070 |
Why?
|
HIV Reverse Transcriptase | 1 | 2008 | 212 | 0.070 |
Why?
|
Oxazines | 2 | 2019 | 341 | 0.070 |
Why?
|
Education, Medical, Graduate | 1 | 2018 | 2359 | 0.060 |
Why?
|
Capsid Proteins | 1 | 2008 | 467 | 0.060 |
Why?
|
Point-of-Care Systems | 1 | 2013 | 1208 | 0.060 |
Why?
|
Bayes Theorem | 1 | 2013 | 2325 | 0.060 |
Why?
|
Curriculum | 1 | 2018 | 3722 | 0.060 |
Why?
|
Attitude of Health Personnel | 1 | 2018 | 3870 | 0.060 |
Why?
|
Pyridones | 2 | 2019 | 788 | 0.060 |
Why?
|
Gene Frequency | 1 | 2010 | 3605 | 0.050 |
Why?
|
Pregnancy | 3 | 2016 | 29725 | 0.050 |
Why?
|
Boston | 1 | 2015 | 9282 | 0.050 |
Why?
|
RNA, Messenger | 3 | 2022 | 12762 | 0.050 |
Why?
|
Clinical Competence | 1 | 2018 | 4786 | 0.050 |
Why?
|
Epitopes | 1 | 2008 | 2506 | 0.050 |
Why?
|
Genotype | 3 | 2022 | 12959 | 0.050 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2008 | 1765 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 12968 | 0.050 |
Why?
|
Prevalence | 2 | 2016 | 15687 | 0.050 |
Why?
|
Male | 7 | 2021 | 359413 | 0.050 |
Why?
|
Developing Countries | 1 | 2013 | 2880 | 0.050 |
Why?
|
Virus Replication | 1 | 2008 | 2431 | 0.050 |
Why?
|
Diabetic Foot | 1 | 2024 | 381 | 0.040 |
Why?
|
Binding Sites | 1 | 2008 | 6050 | 0.040 |
Why?
|
Young Adult | 2 | 2016 | 58673 | 0.040 |
Why?
|
Vaccines, Synthetic | 1 | 2021 | 617 | 0.040 |
Why?
|
Middle Aged | 4 | 2018 | 220175 | 0.040 |
Why?
|
Piperazines | 2 | 2019 | 2520 | 0.040 |
Why?
|
Transcription, Genetic | 1 | 2012 | 7593 | 0.040 |
Why?
|
Health Personnel | 2 | 2022 | 3310 | 0.040 |
Why?
|
Internship and Residency | 1 | 2018 | 5867 | 0.040 |
Why?
|
Disease Outbreaks | 1 | 2007 | 1759 | 0.040 |
Why?
|
Cytokines | 1 | 2012 | 7345 | 0.040 |
Why?
|
Adult | 6 | 2021 | 219847 | 0.040 |
Why?
|
Female | 8 | 2019 | 391011 | 0.040 |
Why?
|
Alleles | 1 | 2008 | 6900 | 0.030 |
Why?
|
Administration, Intranasal | 1 | 2018 | 471 | 0.030 |
Why?
|
Bacterial Infections | 1 | 2024 | 1402 | 0.030 |
Why?
|
Antibodies, Viral | 2 | 2022 | 3145 | 0.030 |
Why?
|
Niacin | 1 | 1996 | 119 | 0.030 |
Why?
|
Amino Acid Substitution | 2 | 2010 | 1737 | 0.030 |
Why?
|
Genetic Variation | 1 | 2010 | 6540 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2010 | 14656 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2015 | 80301 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2010 | 15273 | 0.030 |
Why?
|
Antibodies, Neutralizing | 1 | 2022 | 1933 | 0.030 |
Why?
|
Anti-Retroviral Agents | 1 | 2022 | 1780 | 0.030 |
Why?
|
Vaccination | 1 | 2022 | 3360 | 0.020 |
Why?
|
Mutation | 3 | 2022 | 29950 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2013 | 988 | 0.020 |
Why?
|
United States | 1 | 2017 | 72363 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3618 | 0.020 |
Why?
|
Time Factors | 1 | 2010 | 40133 | 0.020 |
Why?
|
Uncertainty | 1 | 2013 | 754 | 0.020 |
Why?
|
Adolescent | 1 | 2016 | 87747 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2021 | 5420 | 0.020 |
Why?
|
Treatment Failure | 1 | 2010 | 2646 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15827 | 0.010 |
Why?
|
Aged | 1 | 2016 | 168995 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2010 | 64947 | 0.010 |
Why?
|
Community-Acquired Infections | 1 | 2007 | 461 | 0.010 |
Why?
|
Immunologic Factors | 1 | 2012 | 1589 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20048 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2018 | 3762 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2010 | 4717 | 0.010 |
Why?
|
Biological Availability | 1 | 1996 | 395 | 0.010 |
Why?
|
Cell Line | 1 | 2008 | 15626 | 0.010 |
Why?
|
Recurrence | 1 | 2007 | 8487 | 0.010 |
Why?
|
Pharmacists | 1 | 1996 | 259 | 0.010 |
Why?
|
Animals | 1 | 2024 | 167940 | 0.010 |
Why?
|
Professional-Patient Relations | 1 | 1996 | 725 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2010 | 26168 | 0.010 |
Why?
|
Interprofessional Relations | 1 | 1996 | 989 | 0.010 |
Why?
|
Infant | 1 | 2010 | 36030 | 0.000 |
Why?
|
Patient Education as Topic | 1 | 1996 | 2311 | 0.000 |
Why?
|
Physicians | 1 | 1996 | 4590 | 0.000 |
Why?
|